Advancing Cancer Treatment Through Research & Innovation
Our research focuses on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Current Research Projects
Our current research projects are focused on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Efficacy of Compression Therapy for Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients with Early Breast Cancer: Insights from a Single-Centre Experience in Bangladesh
Prospective
Research Objectives:
- • Incidence of CTCAE version 5 grade 2 or higher CIPN in both upper and lower extremities during entire period of chemotherapy.
The Efficacy of Pembrolizumab for Treatment of Early Triple Negative Breast Cancer: A Single-center, Open, Randomized Controlled Trial
Primary endpoints: A) Pathological Complete Response at the time of definitive surgery B) Event-free survival in the intention-to-treat population Secondary endpoints: Overall survival at the end of 15 months
Research Objectives:
- • A prospective study to measure the efficacy of Pembrolizumab in Early Triple Negative Breast Cancer (TNBC) patients of Bangladeshi population.
Recent Publications
Peer-reviewed research contributions published in leading oncology journals, advancing the field of cancer treatment.
Primary Ovarian Non-Hodgkin’s Lymphoma with Late Diagnosis Due to Unusual Presentation - A Case Report
Involvement of NHL in ovary is seen in disseminated Lymphoma but primary ovarian lymphoma still not commonly seen. We presented the case where the patient had suffered for unexplained fever …
Key Findings:
Treated with R-CHOP protocol for 6 cycles as IHC expressed CD20 positive. Post chemotherapy follow up PET scan showed complete response of treatment, though in …
Primary Rectal Non-Hodgkin's Lymphoma Treated with Urgent Radiotherapy and Chemotherapy: A Case Report and Literature Review
Rectal malignancy is usually symptomatic due to its location, and most of the time presents with pain and bleeding due to its growth and ulceration. It is difficult to identify …
Key Findings:
We describe the case of a 49-year-old male from Bangladesh with the same presentation. His treatment was delayed for more than a month as immunohistochemistry …
Single Center Epidemiological Prevalence Study of Molecular Mutation in Bangladeshi Patients with Advanced Stage Non-Small Cell Lung Cancer
This study was retrospective and single center, conducted in 35 patients representing the 77% advanced stage lung cancer patients aged 20 years or above with NSCLC in the outpatient department …
Key Findings:
Of 35 patients 63% (22) were male and 37% (13) were female, median age 61 (range 45-86) and 65% (23) test carried out with Liquid …
Showing 13 to 15 of 19 publications
Conference Presentations & Speaking Engagements
Sharing research findings and clinical insights at leading medical conferences worldwide.
ESMO Asia 2025
Clinicopathological pathological characteristics in young breast cancer patient
A single center retrospectives study in a low and middle income country
KSMO 2025
Survival Analysis of CNS patients in Bangladesh – focusing the multidisciplinary approaches among 149 patients in a single centre retrospective analysis from 2018- 2023.
Introduction: Central Nervous Tumor (CNS) tumor is variable survival status due to its location and age groups. We tried to find selected CNS tumors among adult and child with tri-modalities treatment and compared the survival and prognostic factors among 149 patients first time in Bangladesh. Methods: Retrospective analysis was done through hospital information system among CNS tumors patient’s prescription from 2018 to 2023. Follow up was also confirmed through tele conversation where the last follow up was not recent. A model with python created to analyze the survival in different groups with log rank test and COX proportional hazard ratio also tested.
Showing 5 to 6 of 6 presentations